Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Mirago 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Sun Pharmaceutical Industries Ltd

Salt Composition

Mirabegron (50mg)

Overview Mirago 50 Tablet ER

Mirago 50 Extended-Release tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, nasal congestion, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor immediately. Before starting treatment, disclose all current medications and any pre-existing health conditions, including pregnancy or breastfeeding. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their doctor.

Primary Ingredients of Mirago 50 Tablet ER

No text provided. Please provide the text you wish me to rephrase.

Uses of Mirago 50 Tablet ER

Managing symptoms associated with overactive bladder

Major Benefits of Mirago 50 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mirago 50 ER tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistent timing is recommended.

Common Side effects of Mirago 50 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Mirago 50 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Mirago 50 ER tablets can be consumed with or without food, though consistent timing is recommended.

How Mirago 50 Tablet ER works:

Mirago 50 Extended-Release Tablets contain a beta-3 adrenergic agonist. Its mechanism of action involves stimulating bladder beta-3 receptors, leading to detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

It's recommended to avoid alcohol while taking Mirago 50 Tablet ER. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mirago 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Mirago 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Mirago 50 ER tablets.

KidneyKidneyCAUTION

For patients with severe kidney impairment, Mirago 50 Extended-Release tablets require careful administration. Dosage modification of Mirago 50 Extended-Release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Mirago 50 ER tablets cautiously, potentially requiring dosage modification. Consult your physician. Mirago 50 ER tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Mirago 50 Tablet ER :

For Mirago 50 Tablet ER, take a missed dose promptly if you remember. However, if your next dose is nearly due, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Mirago 50 Tablet ER

LabelValue
Chemical Type Anilide-based compound
Developing Habits No.
Treatment Category Urology
Action class Beta-3 agonist for bladder control

FAQs on Mirago 50 Tablet ER

Mirago 50 Tablet ER's full effects may become apparent after 8 weeks or more of treatment. Dosage adjustments may be considered after 4–8 weeks, depending on individual response.
Continue taking Mirago 50 Tablet ER, even if your symptoms improve. This medication doesn't cure overactive bladder; it manages urgency, frequent urination, and incontinence. Stopping treatment could bring back your symptoms.
Mirago 50 Tablet ER shouldn't interfere with your sleep. However, consult your doctor about any sleep problems you experience.
Mirago 50 Tablet ER should not be given to children under 18, as its safety and efficacy in this age group haven't been established.
Daily use, as prescribed, is essential. This medication manages your condition, not curing it. Consistent use allows your bladder to adjust; intermittent use prevents optimal results and may cause symptoms to return.
Mirago 50 Tablet ER may cause urinary tract infections (kidneys, ureters, bladder, or urethra), though this is not universal. Renal stones and bladder pain are rare side effects. Patients with impaired kidney function should use caution and report any kidney-related symptoms to their doctor.
Caution is advised when taking Mirago 50 Tablet ER if you have high blood pressure. Regular blood pressure monitoring is recommended as this medication may elevate blood pressure in some individuals. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help if you suspect a Mirago 50 Tablet ER overdose, even without symptoms. Overdosing can raise your heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Mirago 50 Tablet ER
316
MRP 385
17% off